Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera.

Metsera currently has no products on the market, but is developing oral and injectable treatments for obesity and diabetes.

Novo Nordisk attempts to acquire weight-loss drug company Metsera during government shutdown, potentially avoiding FTC ...

All of this has weighed on stock performance, leaving the shares down almost 50% over the past three years. Considering this, ...

Pfizer has filed a lawsuit against Novo Nordisk and Metsera in an attempt to force through its takeover of the weight-loss drug developer and prevent Novo Nordisk from taking its rival bid forward.

Novo Nordisk, a leading global healthcare company founded in 1923 and headquartered in Denmark, announced that it has submitted an unsolicited proposal to acquire Metsera, Inc. The acquisition of ...

Pfizer (PFE) could use its connections within President Donald Trump’s administration to try to best Novo Nordisk’s (NVO) rival bid to acquire U.S. obesity biotech firm Metsera (MTSR), Reuters’ ...

Elsewhere, the busy earnings season continues with reports due from several notable companies such as Advanced Micro Devices, Palantir (NASDAQ:PLTR), Robinhood, Super Micro Computer, Qualcomm, ARM ...

CNBC's Charlotte Reed will travel to Copenhagen to speak with Novo Nordisk's new CEO after a bumpy few months.

LONDON, Nov 2 (Reuters Breakingviews) - Welcome back! Donald Trump rated his summit with Xi Jinping a “12 out of 10”. We gave it a lower score. The confab produced an uneasy truce which did not ...